Public Profile

SomnoMed Limited

SomnoMed Limited, headquartered in Australia, is a leading innovator in the field of sleep medicine, specialising in the development of oral appliances for the treatment of obstructive sleep apnoea (OSA). Founded in 2004, the company has established a strong presence in key markets across North America, Europe, and Asia-Pacific, positioning itself as a trusted name in sleep therapy solutions. SomnoMed's flagship products, including the SomnoDent range, are distinguished by their patient-centric design and customisation options, ensuring comfort and efficacy. The company has achieved significant milestones, including regulatory approvals and partnerships with dental professionals, solidifying its market position as a pioneer in non-invasive sleep treatment. With a commitment to improving patient outcomes, SomnoMed continues to lead the way in advancing sleep health solutions globally.

DitchCarbon Score

How does SomnoMed Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

9

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

SomnoMed Limited's score of 9 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.

76%

SomnoMed Limited's reported carbon emissions

SomnoMed Limited, headquartered in Australia, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the company operates within an industry increasingly focused on sustainability and reducing carbon footprints. As such, it is likely that SomnoMed is aware of the importance of addressing climate change and may be exploring strategies to align with industry standards. Further information on their climate commitments or future initiatives would be necessary to provide a comprehensive overview of their environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. SomnoMed Limited's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. SomnoMed Limited is headquartered in AU, which has a rank of very high, indicating very high grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

SomnoMed Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

RespireRx Pharmaceuticals Inc.

US
Health and social work services (85)
Updated 7 days ago

Herbst Gmbh

DE
Updated 4 days ago

James R. Glidewell, Dental Ceramics, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 7 days ago

Tap & Co

US
Updated 4 days ago

Vivos Therapeutics, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers